Crossreactivity studies between sera of patients with heparin associated thrombocytopenia and a new low molecular weight heparin, reviparin.
Greinacher
A
A
Feigl
M
M
Mueller-Eckhardt
C
C
D001323:Autoantibodies / Q000097:blood / Q000276:immunology*; D001327:Autoimmune Diseases / Q000139:chemically induced*; D003429:Cross Reactions; D006493:Heparin / Q000009:adverse effects* / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D046911:Macromolecular Substances; D015539:Platelet Activation / Q000187:drug effects; D010978:Platelet Factor 4 / Q000276:immunology* / Q000378:metabolism; D013921:Thrombocytopenia / Q000139:chemically induced / Q000276:immunology*
D001323:Autoantibodies; D046911:Macromolecular Substances; D010978:Platelet Factor 4; D006493:Heparin